GSK sees phase 3 win for Hansoh-partnered ADC in China as validating its ‘priority asset’
Fuente:
FierceBiotech
Hansoh Pharmaceutical’s pair of much-hyped ADCs continue to justify partner GSK’s decision to make them priority programs.